Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06208137
What this trial is testing

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 456
Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24
Not applicableEnded earlyNCT03080792
What this trial is testing

Pre-Exercise for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Cancer, Hematological
University Hospital Heidelberg 14
Testing effectiveness (Phase 2)UnknownNCT05914714
What this trial is testing

Ruxolitinib as GVHD Prophylaxis in AA Patients

Who this might be right for
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
Institute of Hematology & Blood Diseases Hospital, China 46
Early research (Phase 1)Ended earlyNCT00943293
What this trial is testing

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Who this might be right for
PreleukemiaMyeloproliferative DisordersLymphoma+2 more
University of Chicago 1
Not applicableUnknownNCT03659084
What this trial is testing

Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Hospices Civils de Lyon 150
Testing effectiveness (Phase 2)Study completedNCT05090384
What this trial is testing

Pediatric GVHD Low Risk Steroid Taper Trial

Who this might be right for
Acute Graft vs Host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects
John Levine 50
Not applicableNot Yet RecruitingNCT06758726
What this trial is testing

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Active Not RecruitingNCT04098393
What this trial is testing

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT04167514
What this trial is testing

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Who this might be right for
Graft Versus Host Disease (GVHD)
CSL Behring 136
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00823316
What this trial is testing

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Leukemia
Medipost Co Ltd. 10
Very early researchUnknownNCT04626726
What this trial is testing

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Adult B Acute Lymphoblastic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 50
Early research (Phase 1)UnknownNCT01277484
What this trial is testing

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Seoul St. Mary's Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Not applicableStudy completedNCT00167167
What this trial is testing

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia

Who this might be right for
Leukemia, Myeloid, ChronicAMLMDS+1 more
Masonic Cancer Center, University of Minnesota 40
Testing effectiveness (Phase 2)UnknownNCT03454984
What this trial is testing

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 40
Testing effectiveness (Phase 2)WithdrawnNCT00024128
What this trial is testing

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium
Early research (Phase 1)Study completedNCT01758328
What this trial is testing

Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Next Page